Listar por autor "Vollenhoven, Ronald F. van"
Mostrando ítems 1-2 de 2
-
Efficacy and safety of upadacitinib monotherapy in methotrexate-naive patients with moderately-to-severely active rheumatoid arthritis (SELECT-EARLY) : a multicenter, multi-country, randomized, double-blind, active comparator–controlled trial
Vollenhoven, Ronald F. van; Takeuchi, Tsutomu; Pangan, Aileen L.; Friedman, Alan; Mohamed, Mohamed-Eslam F.; Chen, Su; Rischmueller, Maureen; Blanco, Ricardo; Xavier, Ricardo Machado; Strand, Vibeke (2020) [Artículo de periódico]Objective. The SELECT-EARLY trial was undertaken to study the effect of upadacitinib, an oral, reversible Janus kinase 1–selective inhibitor, as monotherapy in patients with predominantly early rheumatoid arthritis who ... -
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis : a sub-analysis of the Phase 3 SELECT-EARLY study
Takeuchi, Tsutomu; Rischmueller, Maureen; Blanco, Ricardo; Xavier, Ricardo Machado; Ueki, Yukitaka; Atsumi, Tatsuya; Su, Chen; Friedman, Alan; Pangan, Aileen L.; Strand, Vibeke; Vollenhoven, Ronald F. van (2021) [Artículo de periódico]Objective: To assess upadacitinib monotherapy versus methotrexate (MTX) in MTX-naïve Japanese patients with rheumatoid arthritis (RA) from the Phase 3 SELECT-EARLY study. Methods: Japanese patients were randomized 2:1:1:1 ...